Figure 1.
Non-susceptibility percentages by year with 95% CIs for clinical S. pseudintermedius isolates in Finland from mid-2011 to the end of 2015. Cochran–Armitage trend test P values were 0.14 for CLI (clindamycin), 0.14 for ERY (erythromycin), 0.86 for FUS (fusidic acid), 0.12 for OXA (oxacillin), 0.22 for SXT (trimethoprim/sulfamethoxazole) and 0.40 for TET (tetracycline).